- Home
- PCVX vs GNW Comparison
PCVX vs GNW Comparison
Compare PCVX & GNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- GNW
- Stock Information
- Founded
- PCVX 2013
- GNW 1871
- Country
- PCVX United States
- GNW United States
- Employees
- PCVX N/A
- GNW N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- GNW Life Insurance
- Sector
- PCVX Health Care
- GNW Finance
- Exchange
- PCVX Nasdaq
- GNW Nasdaq
- Market Cap
- PCVX 4.0B
- GNW 3.3B
- IPO Year
- PCVX 2020
- GNW 2004
- Fundamental
- Price
- PCVX $33.02
- GNW $8.57
- Analyst Decision
- PCVX Strong Buy
- GNW Buy
- Analyst Count
- PCVX 8
- GNW 1
- Target Price
- PCVX $135.00
- GNW $9.50
- AVG Volume (30 Days)
- PCVX 1.5M
- GNW 4.1M
- Earning Date
- PCVX 11-04-2025
- GNW 11-05-2025
- Dividend Yield
- PCVX N/A
- GNW N/A
- EPS Growth
- PCVX N/A
- GNW 512.33
- EPS
- PCVX N/A
- GNW 0.44
- Revenue
- PCVX N/A
- GNW $7,261,000,000.00
- Revenue This Year
- PCVX N/A
- GNW N/A
- Revenue Next Year
- PCVX N/A
- GNW N/A
- P/E Ratio
- PCVX N/A
- GNW $19.47
- Revenue Growth
- PCVX N/A
- GNW N/A
- 52 Week Low
- PCVX $27.66
- GNW $5.99
- 52 Week High
- PCVX $121.06
- GNW $8.74
- Technical
- Relative Strength Index (RSI)
- PCVX 55.75
- GNW 58.80
- Support Level
- PCVX $30.89
- GNW $8.39
- Resistance Level
- PCVX $32.32
- GNW $8.74
- Average True Range (ATR)
- PCVX 1.19
- GNW 0.15
- MACD
- PCVX 0.30
- GNW -0.03
- Stochastic Oscillator
- PCVX 84.68
- GNW 66.00
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About GNW Genworth Financial Inc
Genworth Financial Inc is a diversified insurance holding company that provides various mortgage and life insurance products. The company has three main operating business segments: Enact, Life and Annuities segment and Long-Term Care Insurance. The company's product portfolio includes various financial products such as traditional life insurance, mortgage insurance, fixed annuities, and variable annuities. Majority of the revenue is generated by the Enact segment. The company earns maximum of its revenue in the United States.